TCL Archive In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review November 3, 1978
TCL Archive In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy November 9, 1990
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research October 15, 1999
